Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS

IS:GENIL Turkey Drug Manufacturers - Specialty & Generic
Market Cap
$1.20 Billion
TL42.39 Billion TRY
Market Cap Rank
#19710 Global
#199 in Turkey
Share Price
TL9.42
Change (1 day)
+1.84%
52-Week Range
TL7.17 - TL216.90
All Time High
TL216.90
About

Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi, a pharmaceutical company, manufactures and supplies products to treat rare diseases and disorders worldwide. The company offers its products in various areas, such as neurology, endocrinology, nephrology, oncology, hematology, and pediatric. Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi has collaboration with Sulfateq BV… Read more

Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS - Asset Resilience Ratio

Latest as of September 2025: 0.62%

Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (GENIL) has an Asset Resilience Ratio of 0.62% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
TL106.64 Million
Cash + Short-term Investments
Total Assets
TL17.28 Billion
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2022–2024)

This chart shows how Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents TL0.00 0%
Short-term Investments TL106.64 Million 0.62%
Total Liquid Assets TL106.64 Million 0.62%

Asset Resilience Insights

  • Limited Liquidity: Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS maintains only 0.62% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS Industry Peers by Asset Resilience Ratio

Compare Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
Drug Manufacturers - Specialty & Generic -0.02%
Dongwha Pharm.Co.Ltd
KO:000020
Drug Manufacturers - Specialty & Generic 1.92%
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
Drug Manufacturers - Specialty & Generic 0.46%
Yuhan Corp Preferred
KO:000105
Drug Manufacturers - Specialty & Generic 0.99%
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
Drug Manufacturers - Specialty & Generic 1.81%
Kotra Industries Bhd
KLSE:0002
Drug Manufacturers - Specialty & Generic 9.82%
Yuyu Pharma
KO:000220
Drug Manufacturers - Specialty & Generic 1.74%
Ildong Holdings Co Ltd
KO:000230
Drug Manufacturers - Specialty & Generic 1.57%

Annual Asset Resilience Ratio for Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (2022–2024)

The table below shows the annual Asset Resilience Ratio data for Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.75% TL92.52 Million TL12.31 Billion -0.08pp
2023-12-31 0.83% TL92.90 Million TL11.13 Billion -10.52pp
2022-12-31 11.35% TL418.01 Million TL3.68 Billion --
pp = percentage points